… SH3BGRL3 in the urine of patients with urothelial carcinoma and upregulated SH3BGRL3 in
primary bladder cancer… revealed that SH3BGRL3 participates in cancer cell proliferation in …

… For Urothelial Carcinoma: A novel binding partner of epidermal growth factor receptor …
Hence, we have unveiled that SH3BGRL3 is a novel urinary biomarker for urothelial carcinoma. …

… its co-transcriptional factor TEAD and (iii) TEAD directly bind Twist promoter to … bladder
cancer, high expression of SH3BGRL3 is related to lower survival rate. Interaction of SH3BGRL3 …

… resistance, and diazepam-binding inhibitor (DBI), previously … been identified as potential
prognosis biomarkers. Pollard et al… the SH3BGRL3 protein could serve as a potential prognostic …

… to identify potential diagnostic and prognostic biomarkers for various … domain-binding glutamic
acid-rich-like protein 3 (SH3BGRL3). … Our results demonstrated that SH3BGRL3 peptides …

… prognostic biomarker of these types of tumor. … In this study, we explore the binding conditions
of SH3BGRL3 with … ] found SH3BGRL3 in the urine of patients with urothelial carcinoma, an …

… SH3BGRL3 promotes kidney cancer and bladder cancer progression. However, as a novel
… binding to its promoter region. Collectively, our results indicated SH3BGRL2 might serve as a …

… This study showed that urinary proteins can reflect the pathophysiological changes in
bladder cancer and that important molecules can be used as biomarkers for bladder cancer …

… SH3 domain binding glutamic acid-rich protein like 3 (SH3BGRL3), one of … the development
of HDP and to develop a panel of predictive biomarkers. … factor in urothelial carcinoma [25]. …

… urothelial carcinoma, clear cell renal carcinoma (ccRCC), and glioblastoma [7-13]. In these
studies, SH3BGRL3 was … was upregulated in GC, we then investigated SH3BGRL3 protein …